Related Experiment Videos
Chronic active hepatitis. Aetiological considerations based on clinical and serological studies
Scandinavian Journal of Gastroenterology
|January 1, 1975
Summary
This study on chronic active hepatitis suggests distinct causes, potentially viral or autoimmune. Some cases may be triggered by the laxative oxyphenisatin, particularly in patients with autoantibodies.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Chronic active hepatitis diagnosis relies on morphological changes.
- 85 cases were diagnosed over 7 years in Copenhagen.
- Patients lacked simultaneous Australia antigen and autoantibodies.
Purpose of the Study:
- To analyze clinical, biochemical, and serological variables in chronic active hepatitis.
- To investigate potential etiological differences in chronic active hepatitis.
- To explore the role of oxyphenisatin in chronic liver damage.
Main Methods:
- Retrospective analysis of 85 chronic active hepatitis cases.
- Clinical, biochemical, and serological data assessment.
- Oxyphenisatin challenge test in a subset of patients.
Main Results:
- Significant differences observed in sex, age, disease onset, and biochemical activity between serologically distinct groups.
- Oxyphenisatin challenge induced increased liver biochemical activity in 8 of 19 patients.
- Patients reacting to oxyphenisatin predominantly belonged to the autoantibody-positive group.
Conclusions:
- Chronic active hepatitis may have diverse etiologies, including viral and autoimmune mechanisms.
- Oxyphenisatin is a potential causative agent for chronic liver damage in some patients.
- Autoimmune mechanisms and oxyphenisatin exposure are linked in certain chronic active hepatitis cases.